Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases

International Journal of Antimicrobial Agents

Volumn 47, Issue 4, 2016, Pages 335-339

  Tofas, Polydoros ^a   Skiada, Anna ^a   Angelopoulou, Maria ^a   Sipsas, Nikolaos ^a   Pavlopoulou, Ioanna ^a   Tsaousi, Sofia ^b   Pagoni, Maria ^b   Kotsopoulou, Maria ^c   Perlorentzou, Stavroula ^c   Antoniadou, Anastasia ^a   Pirounaki, Maria ^d   Skoutelis, Athanasios ^b   Daikos, George L ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c METAXA CANCER HOSPITAL   (Greece)

^d HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Carbapenemase; Infection; Klebsiella; Neutropenia

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; CIPROFLOXACIN; COLISTIN; DORIPENEM; FOSFOMYCIN; GENTAMICIN; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APLASTIC ANEMIA; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GREECE; HEMATOLOGIC MALIGNANCY; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MONOTHERAPY; MORTALITY RATE; NEUTROPENIA; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPTIC SHOCK; ADOLESCENT; COMBINATION DRUG THERAPY; COMPLICATION; ENZYMOLOGY; HEMATOLOGIC DISEASE; HOSPITAL; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PROCEDURES; SECRETION (PROCESS); SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG THERAPY, COMBINATION; FEMALE; GREECE; HEMATOLOGIC NEOPLASMS; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84961226996     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.01.011     Document Type: Article

References (20)

1. L.S. Tzouvelekis, A. Markogiannakis, M. Psichogiou, P.T. Tassios, and G.L. Daikos Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions Clin Microbiol Rev 25 2012 682 707
2. M.J. Satlin, D.P. Calfee, L. Chen, K.A. Fauntleroy, S.J. Wilson, S.G. Jenkins, and et al. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies Leuk Lymphoma 54 2013 799 806
3. M.J. Satlin, S.G. Jenkins, and T.J. Walsh The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies Clin Infect Dis 58 2014 1274 1283
4. C. Girmenia, G.M. Rossolini, A. Piciocchi, A. Bertaina, G. Pisapia, D. Pastore, and et al. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy Bone Marrow Transpl 50 2014 282 288
5. N. Andria, O. Henig, O. Kotler, A. Domchenko, I. Oren, T. Zuckerman, and et al. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study J Antimicrob Chemother 70 2015 3146 3153
6. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 379 383
7. European Committee on Antimicrobial Susceptibility Testing Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 3.1 2013 http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-3.1.pdf [accessed 11.02.16]
8. US Food and Drug Administration Highlights of prescribing information: Tygacil®. Silver Spring, MD: FDA. http://www.accessdata.fda.gov/drugsatfda-docs/label/2010/021821s021lbl.pdf [accessed 11.02.16].
9. KPC-2-carrying Klebsiella pneumoniae in Greece (2009-10) J Antimicrob Chemother 66 2011 1510 1513
10. M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, D. Cook, and et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 2003 1250 1256
11. J. Klastersky, L. Ameye, J. Maertens, A. Georgala, F. Muanza, M. Aoun, and et al. Bacteraemia in febrile neutropenic cancer patients Int J Antimicrob Agents 30 2007 S51 S59
12. C.I. Kang, D.R. Chung, K.S. Ko, K.R. Peck, J.H. Song Korean Network for Study of Infectious Diseases Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy Ann Hematol 91 2012 115 121
13. M. Tumbarello, P. Viale, C. Viscoli, M. Trecarichi, F. Tumietto, A. Marchese, and et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy Clin Infect Dis 55 2012 943 950
14. G.L. Daikos, S. Tsaousi, L.S. Tzouvelekis, I. Anyfantis, M. Psichogiou, A. Argyropoulou, and et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems Antimicrob Agents Chemother 58 2014 2322 2328
15. L.S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, and G.L. Daikos Treating infections caused by carbapenemase-producing Enterobacteriaceae Clin Microbiol Infect 20 2014 862 872
16. M. Tumbarello, E.M. Trecarichi, F.G. De Rosa, M. Giannella, D.R. Giacobbe, M. Bassetti, and et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study J Antimicrob Chemother 70 2015 2133 2143
17. G.P. Bodey, and V. Rodriguez Advances in the management of Pseudomonas aeruginosa infections in cancer patients Eur J Cancer 9 1973 435 441
18. G.P. Bodey, E. Middleman, T. Umsawadi, and V. Rodriguez Infections in cancer patients. Results with gentamicin sulfate therapy Cancer 29 1972 1697 1701
19. S. Schimpff, W. Satterlee, V.M. Young, and A. Serpick Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia N Engl J Med 284 1971 1061 1065
20. D. Averbuch, C. Cordonnier, D.M. Livermore, M. Mikulska, C. Orasch, C. Viscoli, and et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011) Haematologica 98 2013 1836 1847